TEQKX Performance — Nuveen Emerging Markets Equity Index Fund, Class A
Data updated: 2026-09-25
TEQKX returned +18.49% year to date and +33.64% over one year to Jul 2026. Annualised returns are +17.65% over 3 years and +6.87% over 5 years. The fund trailed its Emerging Markets Equity category average: $100 invested three years ago grew to $163, against $164 for the category, and to $134 over one year, against $134. Volatility over the past three years was 16.30% a year. In the 12 months to Jul 2026 the fund lost a net $1.1B, and assets reached $9.54B.
TEQKX Growth of $100
What $100 invested in Nuveen Emerging Markets Equity Index Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | TEQKX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $134 | $134 |
| 3 years (Aug 2023 – Jul 2026) | $163 | $164 |
| 5 years (Aug 2021 – Jul 2026) | $139 | $143 |
| Since data start (Aug 2019 – Jul 2026) | $178 | $188 |
TEQKX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +18.49% |
| 1 year | +33.64% |
| 3 years (annualised) | +17.65% |
| 5 years (annualised) | +6.87% |
TEQKX Annual Returns
Calendar-year total returns of Nuveen Emerging Markets Equity Index Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +18.49% |
| 2025 | +32.41% |
| 2024 | +6.36% |
| 2023 | +8.87% |
| 2022 | −20.51% |
| 2021 | −3.36% |
| 2020 | +17.27% |
| 2019 (Aug–Dec) | +9.01% |
TEQKX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +8.1% | +5.7% | −10.0% | +12.8% | +7.9% | +0.5% | −5.9% | — | — | — | — | — |
| 2025 | +2.0% | +0.6% | +1.3% | +0.5% | +3.9% | +6.6% | +1.4% | +1.1% | +6.9% | +3.8% | −2.0% | +2.6% |
| 2024 | −4.6% | +4.7% | +2.3% | −0.2% | +1.6% | +3.0% | +0.9% | +0.8% | +5.8% | −3.9% | −2.5% | −1.1% |
| 2023 | +8.7% | −7.0% | +3.1% | −0.9% | −2.3% | +4.0% | +6.1% | −6.6% | −2.7% | −3.5% | +7.5% | +3.6% |
| 2022 | −0.3% | −4.6% | −2.9% | −5.8% | +1.1% | −5.8% | −0.5% | −0.6% | −11.5% | −2.7% | +15.9% | −2.7% |
| 2021 | +3.1% | +1.0% | −1.2% | +1.5% | +1.5% | +1.3% | −6.8% | +2.0% | −4.1% | +1.1% | −4.1% | +1.8% |
| 2020 | −5.4% | −3.9% | −16.5% | +8.9% | +2.1% | +7.1% | +8.4% | +2.1% | −1.3% | +1.9% | +8.9% | +7.0% |
| 2019 | — | — | — | — | — | — | — | −4.2% | +1.9% | +4.0% | +0.1% | +7.2% |
TEQKX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 16.30%
- 3-year Sharpe ratio: 0.81 (vs 4.5% risk-free rate)
- Best month: +12.84% (Apr 2026)
- Worst month: −9.99% (Mar 2026)
TEQKX Fund Flows
Monthly money in and out of Nuveen Emerging Markets Equity Index Fund, from SEC Form N-PORT.
- 12-month net flow: −$1.1B
- 12-month gross sales (incl. reinvestments): $1.6B
- Sales ÷ redemptions: 0.60×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $109.8M | $197.1M | −$87.3M |
| Jun 2026 | $193.2M | $128.3M | $64.9M |
| May 2026 | $151.3M | $199.0M | −$47.7M |
| Apr 2026 | $267.3M | $44.6M | $222.7M |
| Mar 2026 | $87.9M | $512.7M | −$424.9M |
| Feb 2026 | $35.2M | $426.5M | −$391.3M |
| Jan 2026 | $69.9M | $240.0M | −$170.1M |
| Dec 2025 | $371.7M | $242.3M | $129.4M |
| Nov 2025 | $84.5M | $54.1M | $30.4M |
| Oct 2025 | $37.8M | $64.3M | −$26.5M |
| Sep 2025 | $42.6M | $531.2M | −$488.6M |
| Aug 2025 | $156.3M | $37.1M | $119.2M |
TEQKX Assets Under Management
Net assets of Nuveen Emerging Markets Equity Index Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $9.54B |
| 2026-04-30 | $9.40B |
| 2026-01-31 | $9.30B |
| 2025-10-31 | $8.81B |
| 2025-07-31 | $8.13B |
| 2025-04-30 | $7.22B |
| 2025-01-31 | $7.32B |
| 2024-10-31 | $6.96B |
| 2024-07-31 | $6.66B |
| 2024-04-30 | $6.25B |
| 2024-01-31 | $5.68B |
| 2023-10-31 | $5.20B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.